CN Patent

CN110494422A — 4-甲基-3-喹啉-3-基乙炔基-苯甲酸n’-(2-氯-6-甲基-苯甲酰基)酰肼的新型无定形分散体

Assigned to Sun Pharma Advanced Research Co Ltd · Expires 2019-11-22 · 6y expired

What this patent protects

本发明提供了一种口服固体剂型，其包含式I化合物： 和可熔聚合物载体的混合物；并且任选地包含药学上可接受的赋形剂，其中混合物是无定形分散体。

USPTO Abstract

本发明提供了一种口服固体剂型，其包含式I化合物： 和可熔聚合物载体的混合物；并且任选地包含药学上可接受的赋形剂，其中混合物是无定形分散体。

Drugs covered by this patent

Patent Metadata

Patent number
CN110494422A
Jurisdiction
CN
Classification
—
Expires
2019-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharma Advanced Research Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.